Sterne, Kessler, Goldstein & Fox PLLC
RSPO3 binding agents and uses thereof
The present invention relates to RSPO-binding agents, particularly RSPO3-binding agents and methods of using the agents for treating diseases such as cancer. The present invention provides antibodies that specifically bind human RSPO3 proteins and modulate β-catenin activity. The present invention further provides methods of using agents that modulate the activity of RSPO3 proteins and inhibit tumor growth. Also described are methods of treating cancer comprising administering a therapeutically effect amount of an agent or antibody of the present invention to a patient having a tumor or cancer.
OncoMed Pharmaceuticals, Inc.
A A C C C A C A A C A A C C C C A C C C C C C
A61K A61K C07K C07K C07K A61K C07K A61P A61P C12Q A61K A61P C07K C12Q C07K C07K A61K C07K C07K C07K C07K C07K C12Q
additional inventional additional additional additional inventional additional inventional inventional additional inventional inventional additional additional additional inventional additional additional inventional additional inventional additional inventional
Christopher J. Austin L.
Bond Gurney